已核实 DOI PubMed 相关产品: 0

Selenium-doped hydroxyapatite biopapers with an anti-bone tumor effect by inducing apoptosis

Journal 2019 · IF 5.251 · 7(12): 5044-5053 · 发表于 2019 年 9 月 4 日
作者: Zi-Fei Zhou,Tuan-Wei Sun,Yun-Hao Qin,Ying-Jie Zhu,Ying-Ying Jiang,Yang Zhang,Jun-Jian Liu,Jin Wu,Shi-Sheng He,Feng Chen
阅读全文 在 PubMed 查看

摘要

One-dimensional hydroxyapatite (HA) particularly mimics the structure of mineralized collagen fibrils and displays superior mechanical properties such as toughness. Herein, we report Se-doped HA/chitosan (Se-HA/CS) biopapers constructed with self-assembled Se-doped HA nanowires and chitosan. The Se-HA/CS biopapers with high flexibility and manufacturability can not only be further processed into arbitrary shapes by folding or using scissors but also display high performances in in vitro/vivo anti-bone tumor studies. The Se-HA/CS biopapers are more inclined to inhibit the growth of tumor cells (HCS 2/8 and SJSA cells) than that of normal human bone marrow stromal cells (hBMSCs). The potential mechanisms of this meaningful anti-tumor effect were investigated, such as reactive oxygen species accumulation and the activation of apoptosis and the underlying signal pathway involved (including caspase family, Bcl-2 family and JNK/STAT3). The results demonstrate that Se-HA/CS biopapers may inhibit the growth of HCS 2/8 and SJSA cells by synchronously inducing JNK activation and STAT3 inhibition and consequently promote the apoptosis of these cells. Furthermore, the in vivo anti-tumor studies confirm that the Se-HA/CS biopapers obviously suppress the growth of patient-derived xenograft tumor models.